JAMES HUTCHERSON: Open Payments
NPI 1477756542 · GUNTERSVILLE, AL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$451 in 24 payments from 11 companies in 2025. Trend: 2023 $242 · 2024 $246 · 2025 $451
Food & beverage: $451
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 10 | $179 |
| Corcept Therapeutics | 3 | $70 |
| Sumitomo Pharma America, Inc. | 2 | $49 |
| PFIZER INC. | 2 | $30 |
| Vanda Pharmaceuticals Inc. | 1 | $21 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 1 | $20 |
| Lilly USA, LLC | 1 | $19 |
| Boston Scientific Corporation | 1 | $18 |
| AstraZeneca Pharmaceuticals LP | 1 | $16 |
| Axsome Therapeutics, Inc. | 1 | $15 |
Products named: Rybelsus, Korlym, Ozempic, GEMTESA, NURTEC ODT, FANAPT, Wegovy, XIFAXAN.
Industry payments across AL — which companies pay providers there.
